Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT02597894
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed primary adenocarcinoma of the prostate
* National Comprehensive Cancer Network (NCCN) high risk disease (cT3 or Gleason score 8-10 or prostate specific antigen \[PSA\] \> 20)
* Not currently on ADT
* Magnetic resonance imaging (MRI) or transrectal doppler ultrasound demonstrating at least one target lesion
* Karnofsky performance status (KPS) \>= 70 or Eastern Cooperative Oncology Group (ECOG) = 2
* Understands the trial and procedure and is willing and able to sign the informed consent form
Exclusion Criteria:
* Patient is unable to receive high dose rate prostate brachytherapy
* Patient is unable to have a MRI or transrectal ultrasound
* Refusal to sign the informed consent
* Patients who are participating in a concurrent treatment protocol
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02597894
Study Brief:
Protocol Section:
NCT02597894